Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE marks third straight day in the red

Wed, 22nd Jan 2020 09:31

* FTSE 100 down 0.5%, FTSE 250 up 0.1%

* Multinationals biggest drag on main index

* Berkeley leads housebuilders higher

* TUI, Burberry also weigh down bluechips

* Ted Baker slides among smallcaps
(Adds company news items, updates share moves)

By Shashwat Awasthi and Muvija M

Jan 22 (Reuters) - London's FTSE 100 recorded its longest
losing streak since early December as a strengthening in
sterling triggered by strong manufacturing sentiment data
weighed on dollar earners, while travel group TUI slid on more
Boeing woes.

The main index reversed earlier gains to decline
0.5% on its third consecutive day in the red.

Homebuilder Berkeley limited losses on the index,
jumping 5.4% to a record high after plans to return 450 million
pounds more to shareholders. An index of housebuilders
scaled over a two-year high on the news.

The FTSE 250 added 0.1%, buoyed by a stronger local
currency.

The pound scaling a five-week high against the euro came as
bets of a cut to the UK interest rate declined after the
Confederation of British Industry reported a pick-up in
manufacturers' sentiment.

That dragged on bluechip exporters including GlaxoSmithKline
, HSBC and British American Tobacco.

A standout faller was TUI, whose London-listed
shares slipped nearly 6% to their lowest since September after
Boeing warned of further delay in returning its grounded
737 MAX airliner to service.

The FTSE 100 missed out as world shares held firm after
Chinese authorities ramped up efforts to control the outbreak of
the coronavirus, which is being likened to the 2002-2003 spread
of Severe Acute Respiratory Syndrome (SARS) and has already led
to nine deaths.

Sage Group outperformed the bourse with a 4% rise as
the software provider reported higher quarterly revenue and
affirmed its annual forecast.

But Burberry slid 5% despite a solid performance
through the Christmas quarter.

"The reminder of how closely the company's fortunes are tied
to China may have provoked some nervousness given the deadly
virus which is currently afflicting the country," AJ Bell
investment director Russ Mould said.

He also suggested that there could be a hint of
profit-taking, given the recent rally in shares.

Further driving the index lower was a dip in Shell
and BP as oil prices weakened, and miner Antofagasta
which fell 4.6% after its copper production was hit by
civil unrest in Chile.

Small-cap fashion retailer Ted Baker sank as much as
10% after it more than doubled its preliminary estimate of an
overstatement in inventory.

A combination of multiple profit warnings, subdued consumer
sentiment and a slew of management changes after allegations of
misconduct against founder Ray Kelvin had knocked more than 70%
off the stock's value last year.
(Reporting by Shashwat Awasthi and Muvija M in Bengaluru;
Editing by Angus MacSwan)

More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.